Advanced Code injection

Therapure Biomanufacturing Announces FDA Approval for Manufacturing of Insmed’s ARIKAYCE®

Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.

OBIO Expands ‘Access to Talent’ Programs, Announces OBIO Job Board - Free Service for Ontario's Health Science Industry

OBIO Expands ‘Access to Talent’ Programs, Announces OBIO Job Board - Free Service for Ontario's Health Science Industry

In response to industry demand, OBIO is proud to announce the launch of the OBIO Job Board, its latest ‘Access to Talent’ program. 

The OBIO Job Board will be hosted on the newly revamped OBIO website and will be free for all health science companies wishing to post their latest health science job openings. 

Canada's Economic Strategy Tables Release Health and Biosciences Report

The report entitled “The Innovation and Competitiveness Imperative: Seizing Opportunities for Growth”, contains recommendations from six sectors with high growth potential, including the health and biosciences sector. The report outlined the roadmap to doubling the size of the health and biosciences sector and becoming a top-three global hub.